[September 17, 2014]

Research and Markets: Global Gene Therapy Market Outlook 2018

Research and Markets (http://www.researchandmarkets.com/research/fgmdrx/global_gene) has announced the addition of the "Global Gene Therapy Market Outlook 2018" report to their offering.

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for difficult to cure' diseases. The gene therapy market, presenting a few marketable products and being nascent in terms of revenue generation, holds tremendous growth potential. As per a new estimation carried out in our latest study, the global gene therapy industry has the potential to become a multi-million dollar industry by the end of 2018, as new products, especially those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.

Primarily, the gene therapy market is dominated by oncology applications with several companies and academic institutions focusing on novel and difficult to treat' cancers. Other therapeutic areas seeing developments in gene therapy include cardiac conditions, inherited blindness, genetic disorders and neurological diseases. An effective analysis of the key therapeutic areas has been included in the report.

Also, a brief overview of the key geographies in the gene therapy market and the regulatory scenario governing the industry has been included to present a balanced outlook Unlike other regions globally, the United States continues to have the maximum number of clinical trials in the gene therapy segment. This shows the country's potential to become a leader in gene therapy in the coming years.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Gene Therapy - An Introduction

Classification of Gene Therapy Techniques

Physical Methods of Gene Transfer

• Electroporation
• Hydrodynamic
• Microinjection
• Particle Bombardment
• Ultrasound-mediated Transfection

Vectors for Gene Therapy

• Adenoviral Vectors
• Adeno-associated Virus Vectors
• Retroviral Vectors
• Lentiviral Vectors
• Plasmid DNA

4. Industry Trends and Drivers

Industry Trends

• Gene Silencing: Gaining Momentum (News - Alert)
• Advanced Therapies: Combining Gene Therapy and Stem Cell Technology
• Immunodeficiency Syndromes: The Focus of Gene Therapy
• Nanotechnology: Empowering Gene Therapy
• Gene Therapy: A New Hope to Treat Blindness
• Gene Therapy: Potential Cure for Cancer

Market Drivers

• Failure of Conventional Therapies to Treat Cancers
• Entry of Gene Therapies in Developed Nations
• Rising Incidence of Chronic and Life Threatening Diseases
• Growing Interest of Venture Capital Firms

5. Market Restraints

• High Cost of Treatment
• Stringent Regulatory Laws & Safety Concerns
• Pitfalls in Current Technique

6. Gene Therapy Market Outlook

• Oncology
• Infectious Diseases
• Genetic Disorders
• Cardiovascular Disorders
• Diabetes Mellitus
• Neurological Disorders

7. Gene Therapy Market - Regulatory Landscape

8. Advanced Gene Therapy Drugs

• Collategene
• Allovectin-7
• Generx
• Glybera

9. Mergers and Acquisitions

• Sangamo BioSciences to Acquire Gene Therapy Company Ceregene.
• Baxter to Acquire Chatham Therapeutics
• Bluebird Bio Acquired Privately Held Gene-Editing Company
• Miltenyi Acquired Gene Therapy Assets from Lentigen
• Dutch Player UniQure to Acquire InoCard GmbH for CHF Therapy.

10. Key Players Analysis (Business Description, Clinical Pipeline, Recent Developments, Strengths & Weaknesses, Key People)

• Spark Therapeutics, LLC
• ViroMed Co. Ltd. dba VM BioPharma
• Advantagene Inc
• Bluebird Bio
• Sanofi
• Genzyme - A Sanofi Company
• Kolon Life Science
• Vical Inc
• Oxford BioMedica
• Genethon

For more information visit http://www.researchandmarkets.com/research/fgmdrx/global_gene

[ Back To TMCnet.com's Homepage ]